Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes

Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes

The neuromuscular junction is the point of contact between motor nerve and skeletal muscle, its vital role in muscle function is reliant on the precise location and function of many proteins. Congenital myasthenic syndromes (CMS) are a heterogeneous group of disorders of neuromuscular transmission w...

Bibliografske podrobnosti
Glavni avtor:	Webster, R
Format:	Journal article
Izdano:	MDPI 2018

Podobne knjige/članki

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
od: Beeson, D, et al.
Izdano: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
od: Beeson, D, et al.
Izdano: (2008)

Congenital myasthenic syndromes and the neuromuscular junction.
od: Cruz, P, et al.
Izdano: (2014)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
od: Beeson, D
Izdano: (2008)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
od: Rodríguez Cruz, P, et al.
Izdano: (2018)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
od: Xufeng Liao, et al.
Izdano: (2023-09-01)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
od: Cossins, J, et al.
Izdano: (2012)

Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
od: Vanhaesebrouck, A
Izdano: (2018)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
od: Healy, E, et al.
Izdano: (2014)

Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
od: Konstantin A. Petrov, et al.
Izdano: (2018-07-01)

The congenital myasthenic syndromes.
od: Palace, J, et al.
Izdano: (2008)

Congenital myasthenic syndromes.
od: Beeson, D, et al.
Izdano: (1997)

Congenital Myasthenic Syndromes
od: J Gordon Millichap
Izdano: (1994-01-01)

Congenital Myasthenic Syndrome
od: WANG Wenqing, et al.
Izdano: (2022-04-01)

Congenital myasthenic syndromes
od: Josef Finsterer
Izdano: (2019-02-01)

Congenital myasthenic syndromes: an update.
od: Finlayson, S, et al.
Izdano: (2013)

Inheritance of Congenital Myasthenic Syndromes
od: J Gordon Millichap
Izdano: (2002-08-01)

Diagnosis of Congenital Myasthenic Syndromes
od: J Gordon Millichap
Izdano: (2004-02-01)

Presynaptic Congenital Myasthenic Syndrome
od: J Gordon Millichap
Izdano: (2001-08-01)

Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
od: Giovannini, F, et al.
Izdano: (2002)

Pathogenic mechanisms of RAPSN mutations in congenital myasthenic syndromes
od: Cheung, JY
Izdano: (2016)

Therapeutic strategies for congenital myasthenic syndromes
od: Lee, M, et al.
Izdano: (2018)

Synaptic dysfunction in congenital myasthenic syndromes.
od: Beeson, D
Izdano: (2012)

DOK7 congenital myasthenic syndrome.
od: Palace, J
Izdano: (2012)

Congenital myasthenic syndromes: recent advances
od: Beeson, D
Izdano: (2016)

Congenital Myasthenic Syndrome with Agrin Mutations
od: J Gordon Millichap, et al.
Izdano: (2014-10-01)

COLQ-Mutant Congenital Myasthenic Syndromes
od: J Gordon Millichap
Izdano: (2008-03-01)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
od: Spillane, J, et al.
Izdano: (2012)

The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: From Electrodiagnostic Findings to Molecular Mechanisms
od: Stefan Nicolau, et al.
Izdano: (2019-03-01)

Congenital myasthenic syndromes: Report of 7 Chile
od: Kleinsteuber, K, et al.
Izdano: (2003)

Congenital myasthenic syndrome caused by mutations in DPAGT.
od: Klein, A, et al.
Izdano: (2015)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
od: Man, S, et al.
Izdano: (2005)

Congenital Myasthenic Syndrome and AChR Mutation
od: J Gordon Millichap
Izdano: (2000-09-01)

DOK7 Mutations in Congenital Myasthenic Syndromes
od: J Gordon Millichap
Izdano: (2007-06-01)

Clinical and genetic basis of congenital myasthenic syndromes
od: Paulo Victor Sgobbi de Souza, et al.

Repouso da junção neuromuscular no tratamento de crises miastênicas e colinérgicas Management of the myasthenic and cholinergic crisis by neuromuscular junction rest
od: J. Lamartine de Assis, et al.
Izdano: (1968-06-01)

A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
od: Webster, R, et al.
Izdano: (2013)

Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
od: Scott P. Ginebaugh, et al.
Izdano: (2022-05-01)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
od: Bonifati, D, et al.
Izdano: (2004)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
od: Finlayson, S, et al.
Izdano: (2013)